News | September 03, 2007

New Guidelines Outline Echo’s Role in Identifying CAD, Imaging

September 4, 2007- New recommendations released today in the Journal of the American Society of Echocardiography further support the role of stress echo in accurately identifying coronary artery disease (CAD), determining prognosis of patients with known or suspected CAD, in addition to providing recommendations for optimizing imaging.

In addition, through advances in the use of stress echo, physicians can tell whether regions of non-contracting heart muscle are still alive, or viable and can determine if these regions are not contracting due to current lack of blood flow to the specific area, or are not contracting due to a prior history of lack of blood flow to the specified area.

The newly released guidelines are an evolution of the 1998 stress echo guidelines published by the American Society of Echocardiography (ASE). With access to more data and continued research, today’s guidelines include refinements in testing protocols, including recommendations on what information should be obtained during stress echo and standards for image interpretation and important progress towards quantitative analysis.

The new guidelines also include recommendations for optimizing imaging. According to the stress echo recommendations for performance, tissue harmonic imaging should be used for stress echocardiography. Tissue harmonic imaging improves the sensitivity of stress echo by reducing near field artifact, improving resolution and enhancing myocardial signals and is superior to fundamental imaging for endocardial border visualization.

Additionally, recommendations encourage physicians to utilize contrast agents during stress echo, in conjunction with harmonic tissue imaging, when two or more of the left ventricular wall segments cannot be clearly viewed. This pairing of contrast agents and harmonic imaging increases the number of visible left ventricular wall segments, improves the accuracy of stress echo readers, enhances diagnostic confidence and reduces the need for additional noninvasive tests.

For more information: www.asecho.org


Related Content

News | Cardiovascular Ultrasound

April 5, 2024 — Cardiawave SA, a French medtech company that has developed an innovative Non-Invasive focused Ultrasound ...

Home April 05, 2024
Home
News | Cardiovascular Ultrasound

August 24, 2023 —Royal Philips, a global leader in health technology, highlighted how it integrates AI in cardiac ...

Home August 24, 2023
Home
News | Cardiovascular Ultrasound

July 27, 2023 —UltraSight, a digital health pioneer transforming cardiac imaging through the power of artificial ...

Home July 27, 2023
Home
Feature | Cardiovascular Ultrasound

February 10, 2023 — GE HealthCare, a leading global precision care innovator, announced that it has signed an agreement ...

Home February 10, 2023
Home
Feature | Cardiovascular Ultrasound | By Paul M Bojarski

Sudden cardiac arrest is a complex and challenging medical emergency because it can occur anywhere at any time and is ...

Home August 23, 2022
Home
News | Cardiovascular Ultrasound

August 9, 2022 — Butterfly Medical, an Israeli medical device company developing a novel minimally invasive solution to ...

Home August 09, 2022
Home
News | Cardiovascular Ultrasound

July 20, 2022 — Teleflex Incorporated, a leading global provider of medical technologies, announced the first patient ...

Home July 20, 2022
Home
Sponsored Content | Videos | Cardiovascular Ultrasound

Enhanced features on the Philips EPIQ CVx ultrasound system provide a next level photorealistic 3D rendering, making it ...

Home July 20, 2022
Home
Sponsored Content | Videos | Cardiovascular Ultrasound

Automated features on the Philips EPIQ CVx cardiology ultrasound system are helping to bring consistency and speed to ...

Home July 07, 2022
Home
News | Cardiovascular Ultrasound

June 15, 2022 — Cardiawave SA, a deeptech medical device manufacturer that has developed Valvosoft, a revolutionary non ...

Home June 15, 2022
Home
Subscribe Now